Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke
Molecular Therapy · 2024
DOI: 10.1016/j.ymthe.2024.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Jui-Sheng Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Anatomy, National Defense Medical Center, Taipei 114, Taiwan. Hauptthemen laut MEDLINE: Platelet Activation, Signal Transduction, Stroke, Reperfusion Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taiwan Ministry of Science and Technology, Research Council of Finland, Sigrid Juséliuksen Säätiö.
Themen: Schlaganfall
Abstract (Originalsprache)
Cerebral reperfusion injury in stroke, stemming from interconnected thrombotic and inflammatory signatures, often involves platelet activation, aggregation and its interaction with various immune cells, contributing to microvascular dysfunction. However, the regulatory mechanisms behind this platelet activation and the resulting inflammation are not well understood, complicating the development of effective stroke therapies. Utilizing animal models and platelets from hemorrhagic stroke patients, our research demonstrates that human cerebral dopamine neurotrophic factor (CDNF) acts as an endogenous antagonist, mitigating platelet aggregation and associated neuroinflammation. CDNF moderates mitochondrial membrane potential, reactive oxygen species production, and intracellular calcium in activated platelets by interfering with GTP binding to Rap1b, thereby reducing Rap1b activation and downregulating the Rap1b-MAPK-PLA2 signaling pathway, which decreases release of the pro-inflammatory mediator thromboxane A2. In addition, CDNF reduces the inflammatory response in BV2 microglial cells co-cultured with activated platelets. Consistent with ex vivo findings, subcutaneous administration of CDNF in a rat model of ischemic stroke significantly reduces platelet activation, aggregation, lipid mediator production, infarct volume, and neurological deficits. In summary, our study highlights CDNF as a promising therapeutic target for mitigating platelet-induced inflammation and enhancing recovery in stroke. Harnessing the CDNF pathway may offer a novel therapeutic strategy for stroke intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Anatomy, National Defense Medical Center, Taipei 114, Taiwan.
- Neuroscience Center, HiLIFE, University of Helsinki, 00014 Helsinki, Finland; Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland.
- Department of Pharmacology, National Defense Medical Center, Taipei 114, Taiwan.
- PhD Program in Pharmacology and Toxicology, Tzu Chi University, 970 Hualien County, Hualien, Taiwan; Neuro-Medical Scientific Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 970 Hualien County, Hu…
- Department of Neurological Surgery, Tri-Service General Hospital and National Defense Medical Center, Taipei 114, Taiwan.
- PhD Program in Pharmacology and Toxicology, Tzu Chi University, 970 Hualien County, Hualien, Taiwan.
Förderung
- Taiwan Ministry of Science and Technology
- Research Council of Finland
- Sigrid Juséliuksen Säätiö
- Ministry of Science and Technology, Taiwan
- Academy of Applied Science Inc
- Tri-Service General Hospital
- Technology Academy Finland
- National Defense Medical Center
Zitieren
APA
Wu, J. S., Lõhelaid, H., Shih, C. C., Liew, H. K., Wang, V., Hu, W. F., Chen, Y. H., Saarma, M., Airavaara, M., & Tseng, K. Y. (2024). Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.09.005
Vancouver
Wu JS, Lõhelaid H, Shih CC, Liew HK, Wang V, Hu WF, et al. Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.09.005
BibTeX
@article{Wu2024,
author = {Wu, Jui-Sheng and Lõhelaid, Helike and Shih, Chih-Chin and Liew, Hock-Kean and Wang, Vicki and Hu, Wei-Fen and Chen, Yuan-Hao and Saarma, Mart and Airavaara, Mikko and Tseng, Kuan-Yin},
title = {Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke},
journal = {Molecular Therapy},
year = {2024},
doi = {10.1016/j.ymthe.2024.09.005}
}
EUVIMED